Losartan potassium and Macitentan drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Losartan potassium (losartan potassium) and Macitentan (macitentan). Common drug interactions include dyspnoea among females and death among males.

The phase IV clinical study analyzes what interactions people have when they take Losartan potassium and Macitentan. It is created by eHealthMe based on reports of 26 people who take the same drugs from the FDA, and is updated regularly.

What is Losartan potassium?

Losartan potassium has active ingredients of losartan potassium. It is often used in high blood pressure. eHealthMe is studying from 51,511 Losartan potassium users. Check the latest studies of Losartan potassium.

What is Macitentan?

Macitentan has active ingredients of macitentan. eHealthMe is studying from 7,371 Macitentan users. Check the latest studies of Macitentan.



On Jul, 19, 2026

26 people who take Losartan potassium and Macitentan together, and have interactions are studied.

Losartan potassium and Macitentan drug interactions.

What are the common drug interactions of Losartan Potassium and Macitentan, by gender? *:

female:

  1. Dyspnoea (difficult or laboured respiration)
  2. Anaemia (lack of blood)
  3. Fatigue (feeling of tiredness)
  4. Productive cough
  5. Oedema peripheral (superficial swelling)
  6. Bronchitis (inflammation of the mucous membrane in the bronchial tubes)
  7. Fluid retention (an abnormal accumulation of fluid in the blood)
  8. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  9. Pulmonary hypertension (increase in blood pressure in the lung artery)
  10. Pyrexia (fever)

male:

  1. Death
  2. Diarrhoea
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Mitral valve disease (disease of mitral valve of heart)
  5. Respiratory tract congestion (blockage on respiratory system)
  6. Dyspnoea (difficult or laboured respiration)
  7. Productive cough
  8. Renal impairment (severely reduced kidney function)
  9. Left ventricular failure (left ventricle fails to contract forcefully)
  10. Arrhythmia (irregular heartbeat)

What are the common drug interactions of Losartan Potassium and Macitentan, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Anaemia (lack of blood)
  2. Haemoglobin decreased
  3. Platelet count decreased
  4. White blood cell count decreased

50-59:

  1. Oedema peripheral (superficial swelling)
  2. Infected skin ulcer
  3. Cardiac failure
  4. Cardiac failure congestive
  5. Dyspnoea exertional (breathlessness or shortness of breath)
  6. Ejection fraction (the percentage of blood that is pumped out of a filled ventricle as a result of a heartbeat)
  7. Ejection fraction decreased (systolic heart failure)
  8. Electrocardiogram qt prolonged
  9. Left ventricular dysfunction
  10. Orthopnoea (shortness of breath (dyspnea) when lying down)

60+:

  1. Dyspnoea (difficult or laboured respiration)
  2. Productive cough
  3. Mitral valve disease (disease of mitral valve of heart)
  4. Pneumonia
  5. Respiratory tract congestion (blockage on respiratory system)
  6. Left ventricular failure (left ventricle fails to contract forcefully)
  7. Ankle fracture
  8. Arrhythmia (irregular heartbeat)
  9. Arterial occlusive disease (slow process through which arteries throughout the body become progressively narrowed and eventually completely blocked)
  10. Cardiac valve disease (heart valve disease)

What are the existing conditions these people have? *

  1. Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 15 people, 57.69%
  2. Pulmonary Hypertension (increase in blood pressure in the lung artery): 8 people, 30.77%
  3. Hyperuricaemia (level of uric acid in the blood that is abnormally high): 3 people, 11.54%
  4. High Blood Cholesterol: 3 people, 11.54%
  5. Cardiac Disorder: 3 people, 11.54%
  6. Rickets (softening of bones): 2 people, 7.69%
  7. Magnesium Deficiency (lack of magnesium): 2 people, 7.69%
  8. Iron Deficiency Anaemia: 2 people, 7.69%
  9. Hypokalemia (low potassium): 2 people, 7.69%
  10. Hypersensitivity: 2 people, 7.69%

* Approximation only. Some reports may have incomplete information.

Do you take Losartan potassium and Macitentan?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Losartan potassium and Macitentan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Losartan potassium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Macitentan:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Losartan potassium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Macitentan and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies


How the study uses the data?

The study uses data from the FDA. It is based on losartan potassium and macitentan (the active ingredients of Losartan potassium and Macitentan, respectively), and Losartan potassium and Macitentan (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: